A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol. (2018)

First Author: May J
Attributed to:  MRC Centre for Reproductive Health at the University of Edinburgh funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-018-3008-6

PubMed Identifier: 30458863

Publication URI: http://europepmc.org/abstract/MED/30458863

Type: Journal Article/Review

Volume: 19

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215